Series D - NxThera

Series D - NxThera

Investment Firm

Overview

NxThera develops medical technologies to treat a variety of endourology conditions, including BPH.

Announced Date

Dec 03, 2015

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Boston Scientific

Boston Scientific

No designation

Participant Investors

3

Investor Name
Participant InvestorAmerican Medical Systems
Participant InvestorBoston Scientific
Participant InvestorMitsui Global Investment

Round Details and Background

NxThera raised $40000000 on 2015-12-03 in Series D

NxThera develops medical technologies to treat a variety of endourology conditions, including BPH.

Company Funding History

8

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 24, 2013
Venture Round - NxThera
-6.6M
Dec 03, 2015
Series D - NxThera
3-40.0M
Feb 26, 2014
Series C - NxThera
1-25.0M
Oct 04, 2011
Series B - NxThera
3-21.6M

Recent Activity

There is no recent news or activity for this profile.